Hipres 25 Tablet contains Atenolol 25 mg, a selective beta-1 adrenergic receptor blocker primarily used in the management of cardiovascular conditions. Atenolol acts by reducing heart rate, myocardial contractility, and cardiac output, thereby lowering blood pressure and decreasing myocardial oxygen demand. It is indicated for the treatment of hypertension, angina pectoris, and for secondary prevention following myocardial infarction. Additionally, Atenolol may be utilized in certain cases of arrhythmias and to manage symptoms of anxiety. Hipres 25 is administered orally, with dosage individualized based on the patient’s clinical response and condition severity. Common side effects include fatigue, dizziness, and cold extremities, while more serious adverse effects may involve bradycardia, hypotension, and bronchospasm, particularly in patients with pre-existing respiratory conditions. Caution is advised in patients with diabetes, as Atenolol can mask hypoglycemic symptoms. It is contraindicated in individuals with severe bradycardia, heart block greater than first degree, cardiogenic shock, and overt cardiac failure. Regular monitoring of blood pressure, heart rate, and renal function is recommended during therapy. Patients should consult healthcare providers before initiating or discontinuing treatment with Hipres 25 to ensure safe and effective use.